58. “‘Sir’, they said, ‘We remember that while he was still alive that deceiver said, ‘After three days I will rise again.’ ...

HASTINGS, Neb. (KSNB) - This holiday season, make sure the gift you choose for a loved one with Alzheimer’s is both practical and meaningful. The Alzheimer’s Association offers a “Holiday ...

Daryl Carlson is a program manager with the Alzheimer’s Association’s Illinois Chapter. He joined the WGN Evening News to talk about care during the season. And for more information log on to ...

demonstrating sustained and meaningful benefits for early Alzheimer's disease patients, according to results from the Phase IIb/III open-label extension trial. The company noted that continued ...

MINNEAPOLIS — While some studies have suggested that having a mother with Alzheimer’s disease may put you more at risk of developing the disease, a new study finds that having a father with ...

An experimental drug has shown promise in preventing Alzheimer’s for people at higher risk of developing the disease. That’s according to a new study from Washington University School of ...

Editor’s note: CNN Chief Medical Correspondent Dr. Sanjay Gupta and writer Sandee LaMotte are part of the study covered in this story and have written about their experiences. When Penny Ashford ...

(RTTNews) - Genentech, a Roche Group member (RHHBY.OB), Thursday presented new findings at the AD/PD 2025 International Conference in Vienna, highlighting advancements in Alzheimer's and Parkinson ...

Alzheimer's Disease (AD) is characterized by a host of recognizable cognitive symptoms, but many non-cognitive symptoms like sleep changes, anxiety, and depression can be early signs of the disease.

Cassava Sciences (SAVA) shared topline results from the Phase 3 REFOCUS-ALZ study of simufilam in mild-to-moderate AD. Topline data indicate that REFOCUS-ALZ did not meet each of the prespecified ...